Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
338 studies found for:    Open Studies | "Spinal Cord Diseases"
Show Display Options
Rank Status Study
21 Recruiting Bone Strength After Spinal Cord Injury
Condition: Spinal Cord Injury
Interventions: Radiation: DXA;   Radiation: pQCT
22 Recruiting Early Stage Amyotrophic Lateral Sclerosis Phrenic Stimulation
Conditions: Amyotrophic Lateral Sclerosis;   Respiratory Insufficiency
Interventions: Device: phenique nerve stimulation NeurX™ (Synapse Biomedical);   Device: sham phrenic nerve stimulation
23 Recruiting A Study to Assess the Efficacy and Safety of ISIS-SMN Rx in Infants With Spinal Muscular Atrophy
Condition: Spinal Muscular Atrophy
Interventions: Drug: ISIS-SMN Rx;   Procedure: Sham procedure
24 Recruiting Gilenya in Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: Gilenya
25 Recruiting Mean Arterial Blood Pressure Treatment for Acute Spinal Cord Injury
Condition: Acute Spinal Cord Injury
Interventions: Other: Hypotension avoidance;   Other: Induced hypertension
26 Recruiting Combination Therapy of Cord Blood and G-CSF for Patients With Brain Injury or Neurodegenerative Disorders
Conditions: Brain Injury;   Cerebral Palsy;   Amyotrophic Lateral Sclerosis;   Parkinson's Disease
Interventions: Procedure: Umbilical cord blood therapy;   Biological: Filgrastim
27 Recruiting Impact of Early Non Invasive Ventilation in Amyotrophic Lateral Sclerosis (ALS) Patients
Condition: Amyotrophic Lateral Sclerosis
Intervention: Device: Home pressure ventilator model Vivo 40 (BREAS Medical AB)
28 Recruiting Blood Pressure, Cerebral Blood Flow and Cognition in Spinal Cord Injury
Condition: Spinal Cord Injury
Interventions: Drug: Midodrine;   Drug: Placebo
29 Unknown  Acute and Chronic Effects of Inhaled Steroids on Pulmonary Function in Persons With Spinal Cord Injury
Condition: Spinal Cord Injury
Intervention: Drug: Mometasone furoate
30 Recruiting Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance Myography
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Device: EIM Measurements
31 Recruiting Study To Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta in Patients With Machado-Joseph Disease
Condition: Machado-Joseph Disease / Spinocerebellar Ataxia 3
Intervention: Drug: Cabaletta for IV infusion once weekly during 24 weeks
32 Recruiting Clinical Trial Phase Multicentric I/II to Evaluate Safety in Patients With Amyotrophic Sclerosis Lateral
Condition: Amyotrophic Lateral Sclerosis
Interventions: Other: Intravenous administration of placebo;   Drug: Intravenous administration of 1 million of MSC;   Drug: Intravenous administration of 2 million of MSC;   Drug: Intravenous administration of 4 million of MSC
33 Recruiting Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: VP 20629;   Drug: Placebo
34 Recruiting Valproate and Levocarnitine in Children With Spinal Muscular Atrophy
Condition: Spinal Muscular Atrophy
Interventions: Drug: Valproate, Levocarnitine;   Drug: Placebo
35 Recruiting Study to Assess Safety, Tolerability and MTD of a Central Pattern Generator-activating Tritherapy (SPINALON) in Patients With Chronic Spinal Cord Injury
Condition: Spinal Cord Injury
Intervention: Drug: SPINALON (buspirone + levodopa + cardidopa)
36 Not yet recruiting Intraventricular Transplantation of Mesenchymal Stem Cell in Patients With ALS
Condition: Amyotrophic Lateral Sclerosis
Intervention: Biological: Intraventricular injection
37 Recruiting The Reversal of Neuromuscular Adaptation in Human With Spinal Cord Injury II
Condition: Spinal Cord Injury(SCI)
Intervention: Device: home-based ankle continuous passive motion machine.
38 Recruiting Natural History and Biomarkers of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Caused by the C9ORF72 Gene Mutation
Condition: Amyotrophic Lateral Sclerosis
Intervention:
39 Recruiting Therapy in Amyotrophic Lateral Sclerosis With Memantine at 20 mg BID (TAME)
Conditions: Amyotrophic Lateral Sclerosis;   Frontal Temporal Dementia
Interventions: Drug: Memantine;   Drug: Placebo (for Memantine)
40 Unknown  Trial of Ascertaining Individual Preferences for Loved One's Role in End-of-Life
Conditions: Amyotrophic Lateral Sclerosis;   GI Cancer;   Pancreatic Cancer
Interventions: Other: TAILORED Patient Family Decision Making;   Other: standard of care

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years